Volume 2, Issue 2 (Winter 2010)                   Iranian Journal of Blood and Cancer 2010, 2(2): 71-76 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Current Indications of Bone Marrow Transplantation (BMT) in Pediatric Malignant Conditions a Review. Iranian Journal of Blood and Cancer 2010; 2 (2) :71-76
URL: http://ijbc.ir/article-1-176-en.html
Abstract:   (11809 Views)

Hematopoietic stem cell transplantation (HSCT) has been practiced for more than 30 years. Hematological malignancies
are the main indications for this treatment. However, its indications in adults are different from children.
Advances in chemotherapy and target therapy have improved treatment outcome of some of the very high risk
cancers, and changed indications of HSCT in children. Multi-center clinical trials evaluating outcome of childhood
cancers using different therapeutic protocols are needed to precisely define the role of HSCT. A review on the current
literature about HSCT indications in pediatric cancers is presented in this manuscript.

Full-Text [PDF 787 kb]   (8235 Downloads)    
: Original Article | Subject: Pediatric Hematology & Oncology
Received: 2011/03/12 | Published: 2010/02/15

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb